A detailed history of Vanguard Group Inc transactions in Xoma Corp stock. As of the latest transaction made, Vanguard Group Inc holds 405,533 shares of XOMA stock, worth $9.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
405,533
Previous 421,474 3.78%
Holding current value
$9.61 Million
Previous $7.8 Million 25.09%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$19.1 - $26.32 $304,473 - $419,567
-15,941 Reduced 3.78%
405,533 $9.75 Million
Q4 2023

Feb 14, 2024

BUY
$13.82 - $19.13 $94,542 - $130,868
6,841 Added 1.65%
421,474 $7.8 Million
Q3 2023

Nov 14, 2023

BUY
$14.02 - $17.71 $45,186 - $57,079
3,223 Added 0.78%
414,633 $5.84 Million
Q2 2023

Aug 14, 2023

BUY
$17.0 - $21.58 $485,095 - $615,785
28,535 Added 7.45%
411,410 $7.77 Million
Q1 2023

May 15, 2023

BUY
$18.01 - $23.12 $1.43 Million - $1.84 Million
79,475 Added 26.19%
382,875 $8.08 Million
Q4 2022

Feb 10, 2023

BUY
$16.0 - $25.45 $187,552 - $298,324
11,722 Added 4.02%
303,400 $5.58 Million
Q3 2022

Nov 14, 2022

SELL
$15.9 - $29.56 $1.4 Million - $2.6 Million
-88,055 Reduced 23.19%
291,678 $5.22 Million
Q2 2022

Aug 12, 2022

SELL
$17.05 - $28.22 $432,814 - $716,364
-25,385 Reduced 6.27%
379,733 $8.46 Million
Q1 2022

May 13, 2022

SELL
$19.62 - $29.61 $34,099 - $51,462
-1,738 Reduced 0.43%
405,118 $11.3 Million
Q4 2021

Feb 14, 2022

BUY
$20.04 - $27.57 $29,098 - $40,031
1,452 Added 0.36%
406,856 $8.48 Million
Q3 2021

Nov 12, 2021

BUY
$23.51 - $34.79 $340,166 - $503,376
14,469 Added 3.7%
405,404 $10 Million
Q2 2021

Aug 13, 2021

BUY
$29.0 - $40.64 $11.3 Million - $15.9 Million
390,935 New
390,935 $13.3 Million

Others Institutions Holding XOMA

About XOMA Corp


  • Ticker XOMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,450,800
  • Market Cap $271M
  • Description
  • XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...
More about XOMA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.